Kyle Malady

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: DexCom Inc., 3 years.

DexCom Inc. Director
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 3, 2026 Verizon Communications Inc. Open-market sale −1,100 $44.79 $49,269
Oct 27, 2026 Verizon Communications Inc. Open-market sale −1,100 $43.00 $47,300
Oct 20, 2026 Verizon Communications Inc. Open-market sale −1,100 $44.48 $48,928
Oct 6, 2026 Verizon Communications Inc. Open-market sale −1,100 $45.75 $50,325
Sep 29, 2026 Verizon Communications Inc. Open-market sale −1,100 $46.40 $51,040
Sep 22, 2026 Verizon Communications Inc. Open-market sale −1,100 $47.65 $52,415
Sep 15, 2026 Verizon Communications Inc. Open-market sale −1,100 $51.19 $56,309
Sep 8, 2026 Verizon Communications Inc. Open-market sale −1,100 $49.98 $54,978
Sep 1, 2026 Verizon Communications Inc. Open-market sale −1,100 $50.50 $55,550
Aug 25, 2026 Verizon Communications Inc. Open-market sale −1,100 $50.06 $55,066
Aug 18, 2026 Verizon Communications Inc. Open-market sale −1,100 $48.68 $53,548
May 28, 2026 DexCom Inc. Grant or award +5,575 — —
Feb 27, 2026 Verizon Communications Inc. Option exercise +34,020 — —
Feb 27, 2026 Verizon Communications Inc. Shares withheld for tax −16,602 $50.14 $832,424
Feb 27, 2026 Verizon Communications Inc. Option exercise +34,936 — —

Questions about Kyle Malady

What boards is Kyle Malady on?

Kyle Malady sits on the board of DexCom Inc.

How long has Kyle Malady served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.